IBRNvsIDEV
iShares Neuroscience and Healthcare ETF against iShares Core MSCI International Developed Markets ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | IDEV | |
|---|---|---|
| Expense ratio | 0.47% | 0.040% |
| Assets | $6640.17T | $32.2B |
| Net flow, 1 month | −$60K | +$614M |
| Net flow, 1 year | +$2M | +$7B |
| Return, YTD | +1.7% | +7.5% |
| Return, 1 year | +22.3% | +9.9% |
| Avg daily volume | 2K | 1.8M |
| Holdings | 54 | 2281 |
| Listed | Aug 23, 2022 | Mar 20, 2017 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS